Floatz logo

Oxytocin

Prader-Willi Syndrome

University Hospital, Toulouseprotein_peptidePhase 2/3Active
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
69/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the Prader-Willi Syndrome cohort.

Asset / SponsorPhaseRating
Serostim
Corporacion Parc Tauli
Phase 4BBB
Dccr
Soleno Therapeutics, Inc.
Phase 3BB
Omnitrope
University Hospital, Toulouse
Phase 4BB
Guanfacine
Maimonides Medical Center
Phase 4BB
Liraglutide
Vancouver General Hospital
Phase 4BB

View all 32 →

Same molecule, other indications

Oxytocin is also rated in:

chronic pain syndromeActive
BB
Indicative · Phase 4
69 / 100
View asset →
dystociaDormant
BB
Indicative · Phase 4
67 / 100
View asset →
schizophreniaActive
BB
Indicative · Phase 4
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →